Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Livzon Pharmaceutical Group ( (HK:1513) ) has provided an announcement.
Livzon Pharmaceutical Group Inc. has announced a board meeting scheduled for April 23, 2025, to review and approve the company’s unaudited quarterly results for the first quarter of 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting stakeholders and market positioning.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. operates in the pharmaceutical industry, focusing on the development, production, and distribution of pharmaceutical products. The company is based in Zhuhai, China, and is involved in providing a range of healthcare solutions.
YTD Price Performance: -4.93%
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.1B
For a thorough assessment of 1513 stock, go to TipRanks’ Stock Analysis page.